The Trans Tasman Radiation Oncology Group (TROG) is a global leader in radiotherapy research. 1 in 2 cancer patients will benefit from radiotherapy and TROG is working hard on ways to continually improve their treatment.
All types of cancer, one treatment
Working with doctors and researchers mainly in Australia and New Zealand, TROG focuses on cancers that can be treated with radiotherapy such as breast, lung, prostate, skin, head and neck.
Cancer research, a team effort
More than 1,200 researchers and doctors have been involved in TROG research studies. Most studies require patients and so far in excess of 14,000 people have volunteered to participate in more than 90 trials, helping our researchers improve cancer treatments.